GalNAcT-2 activators pertain to a category of chemical compounds that target and enhance the activity of a specific enzyme known as N-acetylgalactosaminyltransferase 2 (GalNAcT-2). This enzyme is a member of a larger family of enzymes called glycosyltransferases, which play critical roles in the process of glycosylation, wherein they facilitate the attachment of sugar molecules to proteins or lipids. GalNAcT-2, in particular, is responsible for the initiation of mucin-type O-linked glycosylation. This is a post-translational modification process where the enzyme catalyzes the transfer of N-acetylgalactosamine (GalNAc) to the hydroxyl group of serine or threonine residues on proteins. The specificity of GalNAcT-2 is governed by certain motifs or sequences within the substrate proteins, and its activity is crucial for the proper function of the glycoproteins it modifies.
The molecules classified as GalNAcT-2 activators are characterized by their ability to increase the enzymatic activity of GalNAcT-2. The enhancement of GalNAcT-2 activity by these activators is achieved through direct interaction with the enzyme, which may result in changes to the enzyme's conformation, stability, or its affinity for substrates. The precise mechanisms by which these activators exert their effects can vary, involving allosteric modulation, binding to the active site, or other means of structural alteration that promote a more active form of the enzyme. The increased activity of GalNAcT-2 due to these activators can influence the extent and patterns of glycosylation on proteins, which in turn can affect the physical stability, distribution, and function of these glycoproteins within biological systems. Understanding the function and regulation of GalNAcT-2 and its activators can thus provide insights into the complex processes of cellular communication and protein modulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Manganese (II) chloride provides Mn2+ ions, which are crucial cofactors for GalNAcT-2. The metal ions bind to the active site of the enzyme, enhancing its conformation for optimal activity. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
This fungal metabolite disrupts Golgi structure and function, which can paradoxically increase the activity of GalNAcT-2 by causing a compensatory upregulation of Golgi enzymes, including glycosyltransferases like GalNAcT-2, once the compound is removed. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
By increasing intracellular calcium levels, the ionophore A23187 can enhance the activity of GalNAcT-2, as calcium ions are important for the proper functioning of the Golgi apparatus where GalNAcT-2 operates. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates cAMP levels and activates PKA, which can lead to phosphorylation of proteins in the Golgi apparatus. This can enhance the activity of GalNAcT-2 by modulating Golgi function and potentially increasing the processing of glycosylation enzymes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin increases cytosolic calcium levels by blocking the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA), which can indirectly enhance GalNAcT-2 activity as part of a stress response that upregulates protein processing in the Golgi. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation by blocking the first step in the synthesis of the lipid-linked oligosaccharide. This can lead to a compensatory increase in O-glycosylation activity, which may enhance the functional activity of GalNAcT-2. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
An inhibitor of Golgi alpha-mannosidase II, swainsonine can result in the accumulation of misfolded glycoproteins, which might lead to enhanced O-glycosylation by GalNAcT-2 as a cellular compensatory mechanism. | ||||||